Short-term cortisol infusion in the brachial artery, with and without inhibiting 11β-hydroxysteroid dehydrogenase, does not alter forearm vascular resistance in normotensive and hypertensive subjects

European Journal of Clinical Investigation

Volumn 32, Issue 12, 2002, Pages 874-881

  Van Uum, S H M ^a   Hermus, A R M M ^a   Sweep, C G J ^a   Walker, B R ^b   Ross, H A ^a   De Leeuw, P W ^c   Lenders, Jacques W M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

11 hydroxysteroid dehydrogenase; Cortisol; Glycyrrhetinic acid; Hypertension; Vascular

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; DRUG VEHICLE; GLUCOSE; GLYCYRRHETINIC ACID; HYDROCORTISONE; PLACEBO;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BRACHIAL ARTERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG BINDING; DRUG EFFECT; FEMALE; FOREARM; HUMAN; HUMAN TISSUE; HYDROCORTISONE BLOOD LEVEL; HYPERTENSION; MALE; PRIORITY JOURNAL; VASCULAR RESISTANCE; VENOUS BLOOD;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; BRACHIAL ARTERY; CASE-CONTROL STUDIES; CORTISONE; DOUBLE-BLIND METHOD; FEMALE; GLYCYRRHETINIC ACID; HUMANS; HYDROCORTISONE; HYDROXYSTEROID DEHYDROGENASES; HYPERTENSION; INFUSIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; VASCULAR RESISTANCE;

EID: 18744407551     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2002.01097.x     Document Type: Article

References (36)

1. Whitworth JA, Saines D, Scoggins BA. Blood pressure and metabolic effects of cortisol and deoxycorticosterone in man. Clin Exp Hypertens 1984;6:795-809.
2. Williamson PM, Kelly JJ, Whitworth JA. Dose-response relationships and mineralocorticoid activity in cortisol-induced hypertension in humans. J Hypertens (Suppl) 1996;14:S37-41.
3. Hamilton BP, Zadik Z, Edwin CM, Hamilton JH, Kowarski AA. Effect of adrenal suppression with dexamethasone in essential hypertension. J Clin Endocrinol Metab 1979;48:848-53.
4. Walker BR, Stewart PM, Shackleton CH, Padfield PL, Edwards CR. Deficient inactivation of cortisol by 11 beta-hydroxysteroid dehydrogenase in essential hypertension. Clin Endocrinol 1993;39:221-7.
5. Tam SH, Kelly JJ, Williamson PM, Whitworth JA. Reflex sympathetic function in cortisol-induced hypertension in humans. Clin Exp Hypertens 1997;19:479-93.
6. Pirpiris M, Sudhir K, Yeung S, Jennings G, Whitworth JA. Pressor responsiveness in corticosteroid-induced hypertension in humans. Hypertension 1992;19:567-74.
7. Sudhir K, Jennings GL, Esler MD, Korner PI, Blombery PA et al. Hydrocortisone-induced hypertension in humans: Pressor responsiveness and sympathetic function. Hypertension 1989;13:416-21.
8. Mangos GJ, Walker BR, Kelly JJ, Lawson JA, Webb DJ, Whitworth JA. Cortisol inhibits cholinergic vasodilation in the human forearm. Am J Hypertens 2000;13:1155-60.
9. Scott BA, Lawrence B, Nguyen HH. Meyer WJ3. Aldosterone and dexamethasone binding in human arterial smooth muscle cells. J Hypertens 1987;5:739-44.
10. Lombes M, Oblin ME, Gasc JM, Baulieu EE, Farman N, Bonvalet JP. Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor. Circ Res 1992;71:503-10.
11. Funder JW, Pearce PT, Smith R, Smith AI. Mineralocorticoid action: Target tissue specificity is enzyme, not receptor, mediated. Science 1988;242:583-5.
12. MacKenzie MA, Hoefnagels WHL, Jansen RWMM, Benraad TJ, Kloppenborg PWC. The influence of glycyrrhetinic acid on plasma cortisol and cortisone in healthy young volunteers. J Clin Endocrinol Metab 1990;70:1637-43.
13. Kotelevtsev Y, Holmes MC, Burchell A, Houston PM, Schmoll D et al. 11Beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proc Nat Ac Sc 1997;94:14924-9.
14. Seckl JR, Walker BR. Minireview: 11Beta-hydroxysteroid dehydrogenase type 1- a tissue-specific amplifier of glucocorticoid action. Endocrinology 2001;142:1371-6.
15. Walker BR, Yau JL, Brett LP, Seckl JR, Monder C et al. 11 Beta-hydroxysteroid dehydrogenase in vascular smooth muscle and heart: Implications for cardiovascular responses to glucocorticoids. Endocrinology 1991;129:3305-12.
16. Smith RE, Little PJ, Maguire JA, Stein Oakley AN, Krozowski ZS. Vascular localization of the 11 beta-hydroxysteroid dehydrogenase type II enzyme. Clin Exp Pharmacol Physiol 1996;23:549-51.
17. Hadoke PW, Christy C, Kotelevtsev YV, Williams BC, Kenyon CJ et al. Endothelial cell dysfunction in mice after transgenic knockout of type 2, but not type 1, 11beta-hydroxysteroid dehydrogenase. Circulation 2001;104:2832-7.
18. van Uum SH, Walker BR, Hermus AR, Sweep CG, Smits P et al. Effect of glycyrrhetinic acid on 11 beta-hydroxysteroid dehydrogenase activity in normotensive and hypertensive subjects. Clin Sci (Lond) 2002;102:203-11.
19. Alzamora R, Michea L, Marusic ET. Role of 11beta-hydroxysteroid dehydrogenase in nongenomic aldosterone effects in human arteries. Hypertension 2000;35:1099-104.
20. Walker BR, Connacher AA, Webb DJ, Edwards CR. Glucocorticoids and blood pressure. A role for the cortisol/ cortisone shuttle in the control of vascular tone in man. Clin Sci Colch 1992;83:171-8.
21. Lovati E, Ferrari P, Dick B, Jostarndt K, Frey BM et al. Molecular basis of human salt sensitivity: The role of the 11beta-hydroxysteroid dehydrogenase type 2. J Clin Endocrinol Metab 1999;84:3745-9.
22. Walker BR, Best R, Shackleton CH, Padfield PL, Edwards CR. Increased vasoconstrictor sensitivity to glucocorticoids in essential hypertension. Hypertension 1996;27:190-6.
23. Meulenberg PM, Hofman JA. The effect of oral contraceptive use and pregnancy on the daily rhythm of cortisol and cortisone. Clin Chim Acta 1990;190:211-21.
24. Weykamp CW, Penders TJ, Schmidt NA, Borburgh AJ, van de Calseyde JF, Wolthers BJ. Steroid profile for urine: Reference values [see comments]. Clin Chem 1989;35:2281-4.
25. De Man AJ, Benraad TJ. Aldosterone secretion rate: Radioimmunoassay versus double isotope dilution derivative assay. Clin Chim Acta 1977;79:489-501.
26. De Man AJ, Hofman JA, Hendriks T, Rosmalen FM, Ross HA, Benraad TJ. A direct radio-immunoassay for aldosterone: Significance of endogenous cortisol. Neth J Med 1980;23:79-83.
27. Meulenberg PM, Ross HA, Swinkels LM, Benraad TJ. The effect of oral contraceptives on plasma-free and salivary cortisol and cortisone. Clin Chim Acta 1987;165:379-85.
28. Christ M, Douwes K, Eisen C, Bechtner G, Theisen K, Wehling M. Rapid effects of aldosterone on sodium transport in vascular smooth muscle cells. Hypertension 1995;25:117-23.
29. 2+ in vascular smooth muscle cells. Circ Res 1995;76:973-9.
30. Wehling M, Spes CH, Win N, Janson CP, Schmidt BM et al. Rapid cardiovascular action of aldosterone in man. J Clin Endocrinol Metab 1998;83:3517-22.
31. Brown PH, Teelucksingh S, Matusiewicz SP, Greening AP, Crompton GK, Edwards CR. Cutaneous vasoconstrictor response to glucocorticoids in asthma [see comments]. Lancet 1991;337:576-80.
32. Teelucksingh S, Mackie AD, Burt D, McIntyre MA, Brett L, Edwards CR. Potentiation of hydrocortisone activity in skin by glycyrrhetinic acid [see comments]. Lancet 1990;335:1060-3.
33. Andrew R, Smith K, Jones GC, Walker BR. Distinguishing the activities of 11beta-hydroxysteroid dehydrogenases in vivo using isotopically labeled cortisol. J Clin Endocrinol Metab 2002;87:277-85.
34. Dunn JF, Nisula BC, Rodbard D. Transport of steroid hormones. Binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endocrinol Metab 1981;53:58-68.
35. Stewart PM, Wallace AM, Valentino R, Burt D, Shackleton CH, Edwards CR. Mineralocorticoid activity of liquorice: 11-Beta-hydroxysteroid dehydrogenase deficiency comes of age. Lancet 1987;2:821-4.
36. Morineau G, Boudi A, Barka A, Gourmelen M, Degeilh F et al. Radioimmunoassay of cortisone in serum, urine, and saliva to assess the status of the cortisol-cortisone shuttle. Clin Chem 1997;43:1397-407.